At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Genetic Epidemiology of Lipoprotein-Lipid Levels
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated May 13, 2016
In Brief
An observational study for Cardiovascular Diseases and 2 related conditions. Completed.
Detailed Summary
To determine the contribution of polymorphic variation in candidate genes involved in lipid metabolism in determining quantitative lipoprotein-lipid levels and cardiovascular risk factors in Anglo and Hispanic populations of the San Luis Valley in southern Colorado. The candidate genes included those for A-IV, B, D, E, H, APO(a), LDL receptor, hepatic lipase, lipoprotein lipase, lethicin cholesterol acyletransferase (LCAT), and cholesteryl ester transfer protein.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Atherosclerosis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 1991
First PostedMay 2000
Study CompletionMar 2002
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartMay 1, 1991
Study CompletionMar 1, 2002
TodayJul 2, 2026
Posted 26.1 years ago